Specialists are debating the best approach in cardiogenic shock after a new analysis of data comparing Impella with ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have shown that increasing survival rates in cardiogenic shock is challenging.

The difference in mortality rate widened in recent years between thyrotoxicosis patients with and without thyroid storm. In 2016, inhospital mortality was 2.88% and 1.82% for those with and without ...

OPERATIONAL MODES -- This user-friendly balloon pump machine offers automatic pumping modes，a fast but consistent inflation rate to prevent your balloons bursting. Handy wire storage keeps the ...

“We believe that the NCE exclusivity strategy is an attractive approach if istaroxime receives FDA approval in cardiogenic shock,” said ... of the SERCA2a calcium pump on the sarcoplasmic ...

The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. For more information, please visit ...

In patients with cardiogenic shock (CS), a percutaneous microaxial ventricular assist device (Impella, Abiomed, Danvers, MA) is a choice for temporary mechanical circulatory support. Given the high ...